Global Endocrine Disruption Screening Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The Endocrine Disruptor Screening is used to screen pesticides, chemicals, and other environmental contaminants for their potential to impact the androgen, estrogen, and thyroid hormone systems.
LPI (LP Information)' newest research report, the “Endocrine Disruption Screening Industry Forecast” looks at past sales and reviews total world Endocrine Disruption Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Endocrine Disruption Screening sales for 2023 through 2029. With Endocrine Disruption Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocrine Disruption Screening industry.
This Insight Report provides a comprehensive analysis of the global Endocrine Disruption Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endocrine Disruption Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endocrine Disruption Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocrine Disruption Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocrine Disruption Screening.
The global Endocrine Disruption Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Endocrine Disruption Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Endocrine Disruption Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Endocrine Disruption Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Endocrine Disruption Screening players cover Creative Bioarray, Xenometrix AG, Charles River Laboratories, Eurofins Scientific, Smithers, SGS SA, JRF Global, M?rieux NutriSciences and Alpha Analytical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocrine Disruption Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The Endocrine Disruptor Screening is used to screen pesticides, chemicals, and other environmental contaminants for their potential to impact the androgen, estrogen, and thyroid hormone systems.
LPI (LP Information)' newest research report, the “Endocrine Disruption Screening Industry Forecast” looks at past sales and reviews total world Endocrine Disruption Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Endocrine Disruption Screening sales for 2023 through 2029. With Endocrine Disruption Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocrine Disruption Screening industry.
This Insight Report provides a comprehensive analysis of the global Endocrine Disruption Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endocrine Disruption Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endocrine Disruption Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocrine Disruption Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocrine Disruption Screening.
The global Endocrine Disruption Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Endocrine Disruption Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Endocrine Disruption Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Endocrine Disruption Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Endocrine Disruption Screening players cover Creative Bioarray, Xenometrix AG, Charles River Laboratories, Eurofins Scientific, Smithers, SGS SA, JRF Global, M?rieux NutriSciences and Alpha Analytical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocrine Disruption Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- In Vitro Screening
- In Vivo Screening
- Agricultural
- Medical
- Environmental
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Creative Bioarray
- Xenometrix AG
- Charles River Laboratories
- Eurofins Scientific
- Smithers
- SGS SA
- JRF Global
- M?rieux NutriSciences
- Alpha Analytical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endocrine Disruption Screening Market Size 2018-2029
2.1.2 Endocrine Disruption Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Endocrine Disruption Screening Segment by Type
2.2.1 In Vitro Screening
2.2.2 In Vivo Screening
2.3 Endocrine Disruption Screening Market Size by Type
2.3.1 Endocrine Disruption Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
2.4 Endocrine Disruption Screening Segment by Application
2.4.1 Agricultural
2.4.2 Medical
2.4.3 Environmental
2.5 Endocrine Disruption Screening Market Size by Application
2.5.1 Endocrine Disruption Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
3 ENDOCRINE DISRUPTION SCREENING MARKET SIZE BY PLAYER
3.1 Endocrine Disruption Screening Market Size Market Share by Players
3.1.1 Global Endocrine Disruption Screening Revenue by Players (2018-2023)
3.1.2 Global Endocrine Disruption Screening Revenue Market Share by Players (2018-2023)
3.2 Global Endocrine Disruption Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENDOCRINE DISRUPTION SCREENING BY REGIONS
4.1 Endocrine Disruption Screening Market Size by Regions (2018-2023)
4.2 Americas Endocrine Disruption Screening Market Size Growth (2018-2023)
4.3 APAC Endocrine Disruption Screening Market Size Growth (2018-2023)
4.4 Europe Endocrine Disruption Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Endocrine Disruption Screening Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Endocrine Disruption Screening Market Size by Country (2018-2023)
5.2 Americas Endocrine Disruption Screening Market Size by Type (2018-2023)
5.3 Americas Endocrine Disruption Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocrine Disruption Screening Market Size by Region (2018-2023)
6.2 APAC Endocrine Disruption Screening Market Size by Type (2018-2023)
6.3 APAC Endocrine Disruption Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Endocrine Disruption Screening by Country (2018-2023)
7.2 Europe Endocrine Disruption Screening Market Size by Type (2018-2023)
7.3 Europe Endocrine Disruption Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endocrine Disruption Screening by Region (2018-2023)
8.2 Middle East & Africa Endocrine Disruption Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Endocrine Disruption Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENDOCRINE DISRUPTION SCREENING MARKET FORECAST
10.1 Global Endocrine Disruption Screening Forecast by Regions (2024-2029)
10.1.1 Global Endocrine Disruption Screening Forecast by Regions (2024-2029)
10.1.2 Americas Endocrine Disruption Screening Forecast
10.1.3 APAC Endocrine Disruption Screening Forecast
10.1.4 Europe Endocrine Disruption Screening Forecast
10.1.5 Middle East & Africa Endocrine Disruption Screening Forecast
10.2 Americas Endocrine Disruption Screening Forecast by Country (2024-2029)
10.2.1 United States Endocrine Disruption Screening Market Forecast
10.2.2 Canada Endocrine Disruption Screening Market Forecast
10.2.3 Mexico Endocrine Disruption Screening Market Forecast
10.2.4 Brazil Endocrine Disruption Screening Market Forecast
10.3 APAC Endocrine Disruption Screening Forecast by Region (2024-2029)
10.3.1 China Endocrine Disruption Screening Market Forecast
10.3.2 Japan Endocrine Disruption Screening Market Forecast
10.3.3 Korea Endocrine Disruption Screening Market Forecast
10.3.4 Southeast Asia Endocrine Disruption Screening Market Forecast
10.3.5 India Endocrine Disruption Screening Market Forecast
10.3.6 Australia Endocrine Disruption Screening Market Forecast
10.4 Europe Endocrine Disruption Screening Forecast by Country (2024-2029)
10.4.1 Germany Endocrine Disruption Screening Market Forecast
10.4.2 France Endocrine Disruption Screening Market Forecast
10.4.3 UK Endocrine Disruption Screening Market Forecast
10.4.4 Italy Endocrine Disruption Screening Market Forecast
10.4.5 Russia Endocrine Disruption Screening Market Forecast
10.5 Middle East & Africa Endocrine Disruption Screening Forecast by Region (2024-2029)
10.5.1 Egypt Endocrine Disruption Screening Market Forecast
10.5.2 South Africa Endocrine Disruption Screening Market Forecast
10.5.3 Israel Endocrine Disruption Screening Market Forecast
10.5.4 Turkey Endocrine Disruption Screening Market Forecast
10.5.5 GCC Countries Endocrine Disruption Screening Market Forecast
10.6 Global Endocrine Disruption Screening Forecast by Type (2024-2029)
10.7 Global Endocrine Disruption Screening Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Creative Bioarray
11.1.1 Creative Bioarray Company Information
11.1.2 Creative Bioarray Endocrine Disruption Screening Product Offered
11.1.3 Creative Bioarray Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Bioarray Main Business Overview
11.1.5 Creative Bioarray Latest Developments
11.2 Xenometrix AG
11.2.1 Xenometrix AG Company Information
11.2.2 Xenometrix AG Endocrine Disruption Screening Product Offered
11.2.3 Xenometrix AG Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Xenometrix AG Main Business Overview
11.2.5 Xenometrix AG Latest Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Endocrine Disruption Screening Product Offered
11.3.3 Charles River Laboratories Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Charles River Laboratories Main Business Overview
11.3.5 Charles River Laboratories Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Endocrine Disruption Screening Product Offered
11.4.3 Eurofins Scientific Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Smithers
11.5.1 Smithers Company Information
11.5.2 Smithers Endocrine Disruption Screening Product Offered
11.5.3 Smithers Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Smithers Main Business Overview
11.5.5 Smithers Latest Developments
11.6 SGS SA
11.6.1 SGS SA Company Information
11.6.2 SGS SA Endocrine Disruption Screening Product Offered
11.6.3 SGS SA Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SGS SA Main Business Overview
11.6.5 SGS SA Latest Developments
11.7 JRF Global
11.7.1 JRF Global Company Information
11.7.2 JRF Global Endocrine Disruption Screening Product Offered
11.7.3 JRF Global Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 JRF Global Main Business Overview
11.7.5 JRF Global Latest Developments
11.8 M?rieux NutriSciences
11.8.1 M?rieux NutriSciences Company Information
11.8.2 M?rieux NutriSciences Endocrine Disruption Screening Product Offered
11.8.3 M?rieux NutriSciences Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 M?rieux NutriSciences Main Business Overview
11.8.5 M?rieux NutriSciences Latest Developments
11.9 Alpha Analytical
11.9.1 Alpha Analytical Company Information
11.9.2 Alpha Analytical Endocrine Disruption Screening Product Offered
11.9.3 Alpha Analytical Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Alpha Analytical Main Business Overview
11.9.5 Alpha Analytical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endocrine Disruption Screening Market Size 2018-2029
2.1.2 Endocrine Disruption Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Endocrine Disruption Screening Segment by Type
2.2.1 In Vitro Screening
2.2.2 In Vivo Screening
2.3 Endocrine Disruption Screening Market Size by Type
2.3.1 Endocrine Disruption Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
2.4 Endocrine Disruption Screening Segment by Application
2.4.1 Agricultural
2.4.2 Medical
2.4.3 Environmental
2.5 Endocrine Disruption Screening Market Size by Application
2.5.1 Endocrine Disruption Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
3 ENDOCRINE DISRUPTION SCREENING MARKET SIZE BY PLAYER
3.1 Endocrine Disruption Screening Market Size Market Share by Players
3.1.1 Global Endocrine Disruption Screening Revenue by Players (2018-2023)
3.1.2 Global Endocrine Disruption Screening Revenue Market Share by Players (2018-2023)
3.2 Global Endocrine Disruption Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENDOCRINE DISRUPTION SCREENING BY REGIONS
4.1 Endocrine Disruption Screening Market Size by Regions (2018-2023)
4.2 Americas Endocrine Disruption Screening Market Size Growth (2018-2023)
4.3 APAC Endocrine Disruption Screening Market Size Growth (2018-2023)
4.4 Europe Endocrine Disruption Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Endocrine Disruption Screening Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Endocrine Disruption Screening Market Size by Country (2018-2023)
5.2 Americas Endocrine Disruption Screening Market Size by Type (2018-2023)
5.3 Americas Endocrine Disruption Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocrine Disruption Screening Market Size by Region (2018-2023)
6.2 APAC Endocrine Disruption Screening Market Size by Type (2018-2023)
6.3 APAC Endocrine Disruption Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Endocrine Disruption Screening by Country (2018-2023)
7.2 Europe Endocrine Disruption Screening Market Size by Type (2018-2023)
7.3 Europe Endocrine Disruption Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endocrine Disruption Screening by Region (2018-2023)
8.2 Middle East & Africa Endocrine Disruption Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Endocrine Disruption Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENDOCRINE DISRUPTION SCREENING MARKET FORECAST
10.1 Global Endocrine Disruption Screening Forecast by Regions (2024-2029)
10.1.1 Global Endocrine Disruption Screening Forecast by Regions (2024-2029)
10.1.2 Americas Endocrine Disruption Screening Forecast
10.1.3 APAC Endocrine Disruption Screening Forecast
10.1.4 Europe Endocrine Disruption Screening Forecast
10.1.5 Middle East & Africa Endocrine Disruption Screening Forecast
10.2 Americas Endocrine Disruption Screening Forecast by Country (2024-2029)
10.2.1 United States Endocrine Disruption Screening Market Forecast
10.2.2 Canada Endocrine Disruption Screening Market Forecast
10.2.3 Mexico Endocrine Disruption Screening Market Forecast
10.2.4 Brazil Endocrine Disruption Screening Market Forecast
10.3 APAC Endocrine Disruption Screening Forecast by Region (2024-2029)
10.3.1 China Endocrine Disruption Screening Market Forecast
10.3.2 Japan Endocrine Disruption Screening Market Forecast
10.3.3 Korea Endocrine Disruption Screening Market Forecast
10.3.4 Southeast Asia Endocrine Disruption Screening Market Forecast
10.3.5 India Endocrine Disruption Screening Market Forecast
10.3.6 Australia Endocrine Disruption Screening Market Forecast
10.4 Europe Endocrine Disruption Screening Forecast by Country (2024-2029)
10.4.1 Germany Endocrine Disruption Screening Market Forecast
10.4.2 France Endocrine Disruption Screening Market Forecast
10.4.3 UK Endocrine Disruption Screening Market Forecast
10.4.4 Italy Endocrine Disruption Screening Market Forecast
10.4.5 Russia Endocrine Disruption Screening Market Forecast
10.5 Middle East & Africa Endocrine Disruption Screening Forecast by Region (2024-2029)
10.5.1 Egypt Endocrine Disruption Screening Market Forecast
10.5.2 South Africa Endocrine Disruption Screening Market Forecast
10.5.3 Israel Endocrine Disruption Screening Market Forecast
10.5.4 Turkey Endocrine Disruption Screening Market Forecast
10.5.5 GCC Countries Endocrine Disruption Screening Market Forecast
10.6 Global Endocrine Disruption Screening Forecast by Type (2024-2029)
10.7 Global Endocrine Disruption Screening Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Creative Bioarray
11.1.1 Creative Bioarray Company Information
11.1.2 Creative Bioarray Endocrine Disruption Screening Product Offered
11.1.3 Creative Bioarray Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Bioarray Main Business Overview
11.1.5 Creative Bioarray Latest Developments
11.2 Xenometrix AG
11.2.1 Xenometrix AG Company Information
11.2.2 Xenometrix AG Endocrine Disruption Screening Product Offered
11.2.3 Xenometrix AG Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Xenometrix AG Main Business Overview
11.2.5 Xenometrix AG Latest Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Endocrine Disruption Screening Product Offered
11.3.3 Charles River Laboratories Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Charles River Laboratories Main Business Overview
11.3.5 Charles River Laboratories Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Endocrine Disruption Screening Product Offered
11.4.3 Eurofins Scientific Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Smithers
11.5.1 Smithers Company Information
11.5.2 Smithers Endocrine Disruption Screening Product Offered
11.5.3 Smithers Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Smithers Main Business Overview
11.5.5 Smithers Latest Developments
11.6 SGS SA
11.6.1 SGS SA Company Information
11.6.2 SGS SA Endocrine Disruption Screening Product Offered
11.6.3 SGS SA Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SGS SA Main Business Overview
11.6.5 SGS SA Latest Developments
11.7 JRF Global
11.7.1 JRF Global Company Information
11.7.2 JRF Global Endocrine Disruption Screening Product Offered
11.7.3 JRF Global Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 JRF Global Main Business Overview
11.7.5 JRF Global Latest Developments
11.8 M?rieux NutriSciences
11.8.1 M?rieux NutriSciences Company Information
11.8.2 M?rieux NutriSciences Endocrine Disruption Screening Product Offered
11.8.3 M?rieux NutriSciences Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 M?rieux NutriSciences Main Business Overview
11.8.5 M?rieux NutriSciences Latest Developments
11.9 Alpha Analytical
11.9.1 Alpha Analytical Company Information
11.9.2 Alpha Analytical Endocrine Disruption Screening Product Offered
11.9.3 Alpha Analytical Endocrine Disruption Screening Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Alpha Analytical Main Business Overview
11.9.5 Alpha Analytical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Endocrine Disruption Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of In Vitro Screening
Table 3. Major Players of In Vivo Screening
Table 4. Endocrine Disruption Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 7. Endocrine Disruption Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 10. Global Endocrine Disruption Screening Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Endocrine Disruption Screening Revenue Market Share by Player (2018-2023)
Table 12. Endocrine Disruption Screening Key Players Head office and Products Offered
Table 13. Endocrine Disruption Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Endocrine Disruption Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Endocrine Disruption Screening Market Size Market Share by Regions (2018-2023)
Table 18. Global Endocrine Disruption Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Endocrine Disruption Screening Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Endocrine Disruption Screening Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Endocrine Disruption Screening Market Size Market Share by Country (2018-2023)
Table 22. Americas Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 24. Americas Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 26. APAC Endocrine Disruption Screening Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Endocrine Disruption Screening Market Size Market Share by Region (2018-2023)
Table 28. APAC Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 30. APAC Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 32. Europe Endocrine Disruption Screening Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Endocrine Disruption Screening Market Size Market Share by Country (2018-2023)
Table 34. Europe Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 36. Europe Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Endocrine Disruption Screening Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Endocrine Disruption Screening
Table 45. Key Market Challenges & Risks of Endocrine Disruption Screening
Table 46. Key Industry Trends of Endocrine Disruption Screening
Table 47. Global Endocrine Disruption Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Endocrine Disruption Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Endocrine Disruption Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Endocrine Disruption Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Creative Bioarray Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 52. Creative Bioarray Endocrine Disruption Screening Product Offered
Table 53. Creative Bioarray Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Creative Bioarray Main Business
Table 55. Creative Bioarray Latest Developments
Table 56. Xenometrix AG Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 57. Xenometrix AG Endocrine Disruption Screening Product Offered
Table 58. Xenometrix AG Main Business
Table 59. Xenometrix AG Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Xenometrix AG Latest Developments
Table 61. Charles River Laboratories Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 62. Charles River Laboratories Endocrine Disruption Screening Product Offered
Table 63. Charles River Laboratories Main Business
Table 64. Charles River Laboratories Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Charles River Laboratories Latest Developments
Table 66. Eurofins Scientific Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 67. Eurofins Scientific Endocrine Disruption Screening Product Offered
Table 68. Eurofins Scientific Main Business
Table 69. Eurofins Scientific Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Eurofins Scientific Latest Developments
Table 71. Smithers Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 72. Smithers Endocrine Disruption Screening Product Offered
Table 73. Smithers Main Business
Table 74. Smithers Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Smithers Latest Developments
Table 76. SGS SA Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 77. SGS SA Endocrine Disruption Screening Product Offered
Table 78. SGS SA Main Business
Table 79. SGS SA Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. SGS SA Latest Developments
Table 81. JRF Global Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 82. JRF Global Endocrine Disruption Screening Product Offered
Table 83. JRF Global Main Business
Table 84. JRF Global Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. JRF Global Latest Developments
Table 86. M?rieux NutriSciences Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 87. M?rieux NutriSciences Endocrine Disruption Screening Product Offered
Table 88. M?rieux NutriSciences Main Business
Table 89. M?rieux NutriSciences Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. M?rieux NutriSciences Latest Developments
Table 91. Alpha Analytical Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 92. Alpha Analytical Endocrine Disruption Screening Product Offered
Table 93. Alpha Analytical Main Business
Table 94. Alpha Analytical Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Alpha Analytical Latest Developments
Table 1. Endocrine Disruption Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of In Vitro Screening
Table 3. Major Players of In Vivo Screening
Table 4. Endocrine Disruption Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 7. Endocrine Disruption Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 10. Global Endocrine Disruption Screening Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Endocrine Disruption Screening Revenue Market Share by Player (2018-2023)
Table 12. Endocrine Disruption Screening Key Players Head office and Products Offered
Table 13. Endocrine Disruption Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Endocrine Disruption Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Endocrine Disruption Screening Market Size Market Share by Regions (2018-2023)
Table 18. Global Endocrine Disruption Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Endocrine Disruption Screening Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Endocrine Disruption Screening Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Endocrine Disruption Screening Market Size Market Share by Country (2018-2023)
Table 22. Americas Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 24. Americas Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 26. APAC Endocrine Disruption Screening Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Endocrine Disruption Screening Market Size Market Share by Region (2018-2023)
Table 28. APAC Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 30. APAC Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 32. Europe Endocrine Disruption Screening Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Endocrine Disruption Screening Market Size Market Share by Country (2018-2023)
Table 34. Europe Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 36. Europe Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Endocrine Disruption Screening Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Endocrine Disruption Screening Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Endocrine Disruption Screening Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Endocrine Disruption Screening
Table 45. Key Market Challenges & Risks of Endocrine Disruption Screening
Table 46. Key Industry Trends of Endocrine Disruption Screening
Table 47. Global Endocrine Disruption Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Endocrine Disruption Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Endocrine Disruption Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Endocrine Disruption Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Creative Bioarray Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 52. Creative Bioarray Endocrine Disruption Screening Product Offered
Table 53. Creative Bioarray Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Creative Bioarray Main Business
Table 55. Creative Bioarray Latest Developments
Table 56. Xenometrix AG Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 57. Xenometrix AG Endocrine Disruption Screening Product Offered
Table 58. Xenometrix AG Main Business
Table 59. Xenometrix AG Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Xenometrix AG Latest Developments
Table 61. Charles River Laboratories Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 62. Charles River Laboratories Endocrine Disruption Screening Product Offered
Table 63. Charles River Laboratories Main Business
Table 64. Charles River Laboratories Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Charles River Laboratories Latest Developments
Table 66. Eurofins Scientific Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 67. Eurofins Scientific Endocrine Disruption Screening Product Offered
Table 68. Eurofins Scientific Main Business
Table 69. Eurofins Scientific Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Eurofins Scientific Latest Developments
Table 71. Smithers Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 72. Smithers Endocrine Disruption Screening Product Offered
Table 73. Smithers Main Business
Table 74. Smithers Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Smithers Latest Developments
Table 76. SGS SA Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 77. SGS SA Endocrine Disruption Screening Product Offered
Table 78. SGS SA Main Business
Table 79. SGS SA Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. SGS SA Latest Developments
Table 81. JRF Global Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 82. JRF Global Endocrine Disruption Screening Product Offered
Table 83. JRF Global Main Business
Table 84. JRF Global Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. JRF Global Latest Developments
Table 86. M?rieux NutriSciences Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 87. M?rieux NutriSciences Endocrine Disruption Screening Product Offered
Table 88. M?rieux NutriSciences Main Business
Table 89. M?rieux NutriSciences Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. M?rieux NutriSciences Latest Developments
Table 91. Alpha Analytical Details, Company Type, Endocrine Disruption Screening Area Served and Its Competitors
Table 92. Alpha Analytical Endocrine Disruption Screening Product Offered
Table 93. Alpha Analytical Main Business
Table 94. Alpha Analytical Endocrine Disruption Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Alpha Analytical Latest Developments
LIST OF FIGURES
Figure 1. Endocrine Disruption Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endocrine Disruption Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Endocrine Disruption Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Endocrine Disruption Screening Sales Market Share by Country/Region (2022)
Figure 8. Endocrine Disruption Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Endocrine Disruption Screening Market Size Market Share by Type in 2022
Figure 10. Endocrine Disruption Screening in Agricultural
Figure 11. Global Endocrine Disruption Screening Market: Agricultural (2018-2023) & ($ Millions)
Figure 12. Endocrine Disruption Screening in Medical
Figure 13. Global Endocrine Disruption Screening Market: Medical (2018-2023) & ($ Millions)
Figure 14. Endocrine Disruption Screening in Environmental
Figure 15. Global Endocrine Disruption Screening Market: Environmental (2018-2023) & ($ Millions)
Figure 16. Global Endocrine Disruption Screening Market Size Market Share by Application in 2022
Figure 17. Global Endocrine Disruption Screening Revenue Market Share by Player in 2022
Figure 18. Global Endocrine Disruption Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Endocrine Disruption Screening Value Market Share by Country in 2022
Figure 24. United States Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Endocrine Disruption Screening Market Size Market Share by Region in 2022
Figure 29. APAC Endocrine Disruption Screening Market Size Market Share by Type in 2022
Figure 30. APAC Endocrine Disruption Screening Market Size Market Share by Application in 2022
Figure 31. China Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Endocrine Disruption Screening Market Size Market Share by Country in 2022
Figure 38. Europe Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Endocrine Disruption Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Endocrine Disruption Screening Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Endocrine Disruption Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endocrine Disruption Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Endocrine Disruption Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Endocrine Disruption Screening Sales Market Share by Country/Region (2022)
Figure 8. Endocrine Disruption Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Endocrine Disruption Screening Market Size Market Share by Type in 2022
Figure 10. Endocrine Disruption Screening in Agricultural
Figure 11. Global Endocrine Disruption Screening Market: Agricultural (2018-2023) & ($ Millions)
Figure 12. Endocrine Disruption Screening in Medical
Figure 13. Global Endocrine Disruption Screening Market: Medical (2018-2023) & ($ Millions)
Figure 14. Endocrine Disruption Screening in Environmental
Figure 15. Global Endocrine Disruption Screening Market: Environmental (2018-2023) & ($ Millions)
Figure 16. Global Endocrine Disruption Screening Market Size Market Share by Application in 2022
Figure 17. Global Endocrine Disruption Screening Revenue Market Share by Player in 2022
Figure 18. Global Endocrine Disruption Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Endocrine Disruption Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Endocrine Disruption Screening Value Market Share by Country in 2022
Figure 24. United States Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Endocrine Disruption Screening Market Size Market Share by Region in 2022
Figure 29. APAC Endocrine Disruption Screening Market Size Market Share by Type in 2022
Figure 30. APAC Endocrine Disruption Screening Market Size Market Share by Application in 2022
Figure 31. China Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Endocrine Disruption Screening Market Size Market Share by Country in 2022
Figure 38. Europe Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Endocrine Disruption Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Endocrine Disruption Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Endocrine Disruption Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Endocrine Disruption Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Endocrine Disruption Screening Market Size Market Share Forecast by Application (2024-2029)
